In T1D and T2D patients, expansion of CD4+ CD28null population is associated with poorer glycemic control and higher excretion of albumin [39], which predispose a risk of development of acute coronary syndrome [13]. The gene discussed is CD4; the disease is type 2 diabetes mellitus.